Grosse Pointe Farms, MI1 Active Studies

Osteoarthritis Clinical Trials in Grosse Pointe Farms, MI

Find 1 actively recruiting osteoarthritis clinical trials in Grosse Pointe Farms, MI. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
150
Enrolling

Recruiting Osteoarthritis Studies in Grosse Pointe Farms

About Osteoarthritis Clinical Trials in Grosse Pointe Farms

Osteoarthritis is the most common form of arthritis, occurring when protective cartilage that cushions the ends of bones wears down over time. It most commonly affects joints in the hands, knees, hips, and spine. Treatment includes exercise, weight management, pain relief, and joint replacement surgery.

There are currently 1 osteoarthritis clinical trials recruiting participants in Grosse Pointe Farms, MI. These studies are seeking a combined 150 participants. Research is being sponsored by Henry Ford Health System. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteoarthritis Clinical Trials in Grosse Pointe Farms — FAQ

Are there osteoarthritis clinical trials in Grosse Pointe Farms?

Yes, there are 1 osteoarthritis clinical trials currently recruiting in Grosse Pointe Farms, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Grosse Pointe Farms?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Grosse Pointe Farms research site will contact you about next steps.

Are clinical trials in Grosse Pointe Farms free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Grosse Pointe Farms studies also compensate for your time and travel.

What osteoarthritis treatments are being tested?

The 1 active trials in Grosse Pointe Farms are testing new therapies including novel drugs, biologics, and treatment approaches for osteoarthritis.

Data updated October 16, 2026 from ClinicalTrials.gov